Defiance Daily Target 2X Long NVO ETF (NVOX)

Assets	$41.27M
Expense Ratio	1.31%
PE Ratio	n/a
Forward PE	n/a
Shares Out	4.30M
Dividend	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	725,573
Open	9.90
Previous Close	9.44
Day's Range	9.86 - 10.18
52-Week Low	8.87
52-Week High	33.81
Beta	n/a
Holdings	12
Inception Date	Dec 2, 2024

About NVOX

Fund Home Page

The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSE Arca
• Ticker Symbol: NVOX
• ETF Provider: Defiance

Top 10 Holdings

299.11% of assets

Name	Symbol	Weight
United States Treasury Bills 0%	B.0 11.19.26	65.76%
NOVO-NORDISK SWAP MS	n/a	43.86%
NOVO-NORDISK INC SWAP CANTOR	n/a	31.06%
NOVO-NORDISK SWAP CLEARSTREET	n/a	30.99%
NOVO-NORDISK SWAP MAREX	n/a	30.25%
NOVO-NORDISK A/S-SPONS ADR NOMURA	n/a	26.86%
NOVO-NORDISK SWAP NBC-L	n/a	25.42%
US DOLLARS	n/a	16.08%
OTHER ASSETS AND LIABILITIES	n/a	14.46%
NOVO-NORDISK SWAP BMO-L	n/a	14.37%

Performance

NVOX had a total return of -65.35% in the past year, including dividends. Since the fund's inception, the average annual return has been -77.77%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error